Jesumoroti OJ - Search Results

1

Nitrothiazole-Thiazolidinone Hybrids: Synthesis and in Vitro Antimicrobial Evaluation.

Hart D, Legoabe LJ, Jesumoroti OJ, Jordaan A, Warner DF, Steventon R, Beteck RM. Hart D, et al. Among authors: jesumoroti oj. Chem Biodivers. 2022 Nov;19(11):e202200729. doi: 10.1002/cbdv.202200729. Epub 2022 Oct 6. Chem Biodivers. 2022. PMID: 36102043

2

Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.

Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM. Patel OPS, et al. Among authors: jesumoroti oj. Eur J Med Chem. 2021 Jan 15;210:112994. doi: 10.1016/j.ejmech.2020.112994. Epub 2020 Nov 4. Eur J Med Chem. 2021. PMID: 33234343 Review.

3

In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3,4-dihydroquinazolin-2(1H)-one Derivatives.

Jesumoroti OJ, Beteck RM, Legoabe LJ. Jesumoroti OJ, et al. Drug Res (Stuttg). 2021 Jul;71(6):335-340. doi: 10.1055/a-1349-1256. Epub 2021 Feb 3. Drug Res (Stuttg). 2021. PMID: 33535253

4

Correction: In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3,4-dihydroquinazolin-2(1H)-one Derivatives.

Jesumoroti OJ, Beteck RM, Legoabe LJ. Jesumoroti OJ, et al. Drug Res (Stuttg). 2021 Jul;71(6):e1. doi: 10.1055/a-1387-6035. Epub 2021 Feb 19. Drug Res (Stuttg). 2021. PMID: 33607656 No abstract available.

5

Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents.

Jesumoroti OJ, Beteck RM, Jordaan A, Warner DF, Legoabe LJ. Jesumoroti OJ, et al. Mol Divers. 2023 Apr;27(2):753-765. doi: 10.1007/s11030-022-10453-1. Epub 2022 May 22. Mol Divers. 2023. PMID: 35598185 Free PMC article.

6

Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.

Dube PS, Legoabe LJ, Jordaan A, Jesumoroti OJ, Tshiwawa T, Warner DF, Beteck RM. Dube PS, et al. Among authors: jesumoroti oj. Eur J Med Chem. 2021 Mar 5;213:113207. doi: 10.1016/j.ejmech.2021.113207. Epub 2021 Jan 24. Eur J Med Chem. 2021. PMID: 33524688

7

Synthesis and biological evaluation of selected 7H-pyrrolo[2,3-d]pyrimidine derivatives as novel CDK9/CyclinT and Haspin inhibitors.

Pieterse L, Beteck RM, Baratte B, Jesumoroti OJ, Robert T, Ruchaud S, Bach S, Legoabe LJ. Pieterse L, et al. Among authors: jesumoroti oj. Chem Biol Interact. 2021 Nov 1;349:109643. doi: 10.1016/j.cbi.2021.109643. Epub 2021 Sep 9. Chem Biol Interact. 2021. PMID: 34508710

8

Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors.

Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R. Jesumoroti OJ, et al. Medchemcomm. 2018 Dec 10;10(1):80-88. doi: 10.1039/c8md00328a. eCollection 2019 Jan 1. Medchemcomm. 2018. PMID: 30774857 Free PMC article.

9

2-Aroyl quinazolinone: Synthesis and in vitro anti-parasitic activity.

Setshedi KJ, Beteck RM, Jesumoroti OJ, Ilbeigi K, Mabille D, Caljon G, Van der Kooy F, Legoabe LJ. Setshedi KJ, et al. Among authors: jesumoroti oj. Chem Biol Drug Des. 2023 Oct;102(4):763-772. doi: 10.1111/cbdd.14284. Epub 2023 Jun 23. Chem Biol Drug Des. 2023. PMID: 37353860

10

Arylnitro monocarbonyl curcumin analogues: Synthesis and in vitro antitubercular evaluation.

du Preez C, Legoabe LJ, Jordaan A, Jesumoroti OJ, Warner DF, Beteck RM. du Preez C, et al. Among authors: jesumoroti oj. Chem Biol Drug Des. 2023 Mar;101(3):717-726. doi: 10.1111/cbdd.14174. Epub 2022 Nov 17. Chem Biol Drug Des. 2023. PMID: 36350112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters